Correction to: Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Lignende værker

• Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
  af: Bibl, Mirko, et al.
  Udgivet: (2012)
• CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
  af: Bibl, Mirko, et al.
  Udgivet: (2006)
• Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
  af: Bibl, Mirko, et al.
  Udgivet: (2010)
• Plasma Amyloid‐BetaPeptides in Acute Cerebral Ischemia: A Pilot Study
  af: Bibl, Mirko, et al.
  Udgivet: (2012)
• Neurochemical biomarkers in Alzheimer’s disease and related disorders
  af: Bibl, Mirko, et al.
  Udgivet: (2012)